What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Kangpu wraps up phase 1 clinical trial of CRL4-CRBN modulator KPG-818 Chinese pharma company Kangpu Biopharmaceuticals said that it has wrapped up the first-in-human phase 1 clinical trial of… bypharmanewsdailyOctober 14, 2019